TORNTPHARM - Torrent Pharmaceuticals Ltd. Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

TORNTPHARM

36/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹4441.00-19.10(-0.43%)

Market Closed as of May 20, 2026, 15:30 IST

Select time range

Pros

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money has been increasing their position in the stock.

Profitability: Very strong Profitability. One year profit margin are 18%.

Momentum: Stock price has a strong positive momentum. Stock is up 8.7% in last 30 days.

Balance Sheet: Strong Balance Sheet.

Size: It is among the top 200 market size companies of india.

Growth: Good revenue growth. With 35.2% growth over past three years, the company is going strong.

Past Returns: Outperforming stock! In past three years, the stock has provided 38.4% return compared to 9.8% by NIFTY 50.

Valuation
Market Cap	1.48 LCr
Price/Earnings (Trailing)	65.27
Price/Sales (Trailing)	11.72
EV/EBITDA	36.84
Price/Free Cashflow	60.57
MarketCap/EBT	49.29
Enterprise Value	1.48 LCr

Fundamentals
Revenue (TTM)	12.65 kCr
Rev. Growth (Yr)	15.8%
Earnings (TTM)	2.27 kCr
Earnings Growth (Yr)	26.2%

Profitability
Operating Margin	24%
EBT Margin	24%
Return on Equity	26.89%
Return on Assets	14.64%
Free Cashflow Yield	1.65%

Growth & Returns
Price Change 1W	4.7%
Price Change 1M	8.7%
Price Change 6M	22.4%
Price Change 1Y	37.5%
3Y Cumulative Return	38.4%
5Y Cumulative Return	27.4%
7Y Cumulative Return	26.6%
10Y Cumulative Return	20.2%

Balance Sheet
Total Assets	15.52 kCr
Total Liabilities	7.07 kCr
Shareholder Equity	8.45 kCr
Current Assets	6.17 kCr
Current Liabilities	4.43 kCr
Net PPE	3.46 kCr
Inventory	2.47 kCr
Goodwill	340 Cr

Dividend & Shareholder Returns
Dividend/Share (TTM)	35
Dividend Yield	0.80%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Technical Indicators
RSI (14d)	65.7
RSI (5d)	100
RSI (21d)	69.07
MACD Signal	Buy
Stochastic Oscillator Signal	Sell
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Sell
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Shareholder Name	Holding %
TORRENT INVESTMENTS LIMITED (FORMERLY KNOWN AS TORRENT INVESTMENTS PRIVATE LIMITED)	68.31%
NPS TRUST	2.49%
Torrent Urja 39 Private Limited	0%
Torrent Urja 40 Private Limited	0%
Torrent Urja 41 Private Limited	0%
Torrent Urja 42 Private Limited	0%
Torrent Urja 43 Private Limited	0%
Torrent Urja 44 Private Limited	0%
Torrent Urja 45 Private Limited	0%
Torrent Urja 46 Private Limited	0%
Torrent Urja 47 Private Limited	0%
Dwarka Renewables Private Limited	0%
Azadirachta Indica Renewables Private Limited	0%
Onix-One Enersol Private Limited	0%
Torrent Gas Chennai Private Limited	0%
Torrent Gas Jaipur Private Limited	0%
Dholpur CGD Private Limited	0%
Radiant Urja LLP	0%
Abhivyakti Enterprise LLP	0%
Akalpya Enterprise LLP	0%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
SUNPHARMA	Sun Pharmaceutical Industries	4.43 LCr	58.94 kCr	+7.80%	+4.60%	40.61	7.52	-	-
CIPLA	Cipla	1.09 LCr	29.37 kCr	+10.80%	-9.40%	23.93	3.7	-	-
LUPIN	Lupin	1.09 LCr	28.38 kCr	+3.70%	+18.10%	20.38	3.83	-	-
DRREDDY	Dr. Reddy's Lab	1.08 LCr	36.09 kCr	+8.60%	+12.70%	19.35	2.99	-	-
AUROPHARMA	Aurobindo Pharma	86.38 kCr	33.73 kCr	+11.40%	+28.50%	24.77	2.56	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	7.3%	11,516	10,728	9,620	8,508	8,005	7,939
Other Income	-61.4%	23	58	45	197	57	122
Total Income	7%	11,539	10,786	9,665	8,705	8,062	8,061
Cost of Materials	-8.3%	1,520	1,657	1,480	1,538	1,421	1,377
Purchases of stock-in-trade	29.3%	1,531	1,184	1,089	831	1,005	923
Employee Expense	11%	2,203	1,984	1,678	1,526	1,440	1,429
Finance costs	-28.9%	252	354	333	255	358	451
Depreciation and Amortization	-1.6%	795	808	707	662	658	654
Other expenses	4.7%	2,816	2,690	2,365	2,108	1,933	2,173
Total Expenses	3.8%	8,842	8,522	7,818	6,994	6,536	6,874
Profit Before exceptional items and Tax	19.1%	2,697	2,264	1,847	1,711	1,526	1,187
Exceptional items before tax	-128.7%	-24	88	0	-485	0	0
Total profit before tax	13.7%	2,673	2,352	1,847	1,226	1,526	1,187
Current tax	34.1%	619	462	374	342	327	221
Deferred tax	-39.1%	143	234	228	107	-53	-59
Total tax	9.5%	762	696	602	449	274	162
Total profit (loss) for period	15.4%	1,911	1,656	1,245	777	1,252	1,025
Other comp. income net of taxes	-687.5%	-93	17	-137	12	100	-192
Total Comprehensive Income	8.7%	1,818	1,673	1,108	789	1,352	833
Earnings Per Share, Basic	15.7%	56.47	48.94	36.79	22.965	36.99	30.275
Earnings Per Share, Diluted	15.7%	56.47	48.94	36.79	0	36.99	30.275
Debt equity ratio	-	04	-	-	-	-	-
Debt service coverage ratio	-	0.0387	-	-	-	-	-
Interest service coverage ratio	-	0.1243	-	-	-	-	-

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	0%	3,303	3,302	3,178	2,959	2,809	2,889
Other Income	50%	-13	-27	-37	-18	33	-16
Total Income	0.5%	3,290	3,275	3,141	2,941	2,842	2,873
Cost of Materials	8.4%	414	382	396	402	370	337
Purchases of stock-in-trade	10.5%	422	382	338	416	420	382
Employee Expense	3.8%	651	627	605	561	549	543
Finance costs	-6.4%	45	48	56	56	57	64
Depreciation and Amortization	1%	206	204	201	201	199	198
Other expenses	-3.4%	765	792	767	703	673	729
Total Expenses	-0.2%	2,466	2,471	2,403	2,252	2,151	2,212
Profit Before exceptional items and Tax	2.5%	824	804	738	689	691	661
Exceptional items before tax	21.4%	-10	-13	0	-24	0	0
Total profit before tax	2.9%	814	791	738	665	691	661
Current tax	4.7%	244	233	201	184	153	156
Deferred tax	-94.1%	-65	-33	-11	-17	35	52
Total tax	-10.6%	179	200	190	167	188	208
Total profit (loss) for period	7.5%	635	591	548	498	503	453
Other comp. income net of taxes	77.9%	-16	-76	-2	36	-70	-25
Total Comprehensive Income	20.2%	619	515	546	534	433	428
Earnings Per Share, Basic	8%	18.77	17.45	16.19	14.71	14.88	13.37
Earnings Per Share, Diluted	8%	18.77	17.45	16.19	14.71	14.88	13.37
Debt equity ratio	-	-	-	-	04	-	-
Debt service coverage ratio	-	-	-	-	0.0491	-	-
Interest service coverage ratio	-	-	-	-	0.1366	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	13.5%	9,682	8,533	7,695	6,742	6,451	6,168
Other Income	-65.6%	32	91	82	204	118	237
Total Income	12.6%	9,714	8,624	7,777	6,946	6,569	6,405
Cost of Materials	-8.1%	1,518	1,652	1,477	1,529	1,421	1,353
Purchases of stock-in-trade	33.6%	732	548	534	397	399	341
Employee Expense	12.8%	1,636	1,451	1,251	1,098	1,097	1,062
Finance costs	-29.8%	213	303	298	236	339	430
Depreciation and Amortization	-0.1%	760	761	672	602	610	607
Other expenses	8.2%	2,230	2,061	1,840	1,636	1,487	1,552
Total Expenses	5.6%	7,080	6,707	6,200	5,480	5,203	5,288
Profit Before exceptional items and Tax	37.4%	2,634	1,917	1,577	1,466	1,366	1,117
Exceptional items before tax	-	-24	0	0	0	0	0
Total profit before tax	36.2%	2,610	1,917	1,577	1,466	1,366	1,117
Current tax	68.2%	541	322	274	253	248	192
Deferred tax	-24.1%	181	238	251	222	-20	-14
Total tax	29%	722	560	525	475	228	178
Total profit (loss) for period	39.2%	1,888	1,357	1,052	991	1,138	939
Other comp. income net of taxes	-240%	-41	31	-78	1	110	-115
Total Comprehensive Income	33.1%	1,847	1,388	974	992	1,248	824
Earnings Per Share, Basic	40.1%	55.79	40.1	31.07	29.295	33.62	27.73
Earnings Per Share, Diluted	40.1%	55.79	40.1	31.07	29.295	33.62	27.73
Debt equity ratio	-	034	-	-	-	-	-
Debt service coverage ratio	-	0.0408	-	-	-	-	-
Interest service coverage ratio	-	0.1443	-	-	-	-	-

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	-5.9%	2,599	2,762	2,616	2,433	2,377	2,434
Other Income	67.9%	-8	-27	-5	15	3	-7
Total Income	-5.3%	2,591	2,735	2,611	2,448	2,380	2,427
Cost of Materials	7.6%	411	382	394	402	369	337
Purchases of stock-in-trade	6.5%	198	186	173	205	211	175
Employee Expense	4.1%	479	460	453	416	407	407
Finance costs	-8.3%	34	37	45	47	48	54
Depreciation and Amortization	1.1%	191	189	187	190	191	190
Other expenses	-4.1%	584	609	600	570	539	571
Total Expenses	-4.8%	1,824	1,916	1,869	1,802	1,729	1,757
Profit Before exceptional items and Tax	-6.4%	767	819	742	646	651	670
Exceptional items before tax	21.4%	-10	-13	0	-24	0	0
Total profit before tax	-6.1%	757	806	742	622	651	670
Current tax	4.6%	230	220	198	160	125	139
Deferred tax	-325%	-50	-11	-7	-12	41	71
Total tax	-13.9%	180	209	191	148	166	210
Total profit (loss) for period	-3.4%	577	597	551	474	485	460
Other comp. income net of taxes	89.3%	-5	-55	-27	-5	-7	-29
Total Comprehensive Income	5.5%	572	542	524	469	478	431
Earnings Per Share, Basic	-3.6%	17.04	17.64	16.28	14	14.33	13.6
Earnings Per Share, Diluted	-3.6%	17.04	17.64	16.28	14	14.33	13.6
Debt equity ratio	-	-	-	-	034	-	-
Debt service coverage ratio	-	-	-	-	0.0511	-	-
Interest service coverage ratio	-	-	-	-	0.1528	-	-

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	8.4%	621	573	1,146	835	538	508
Current investments	-20.7%	89	112	85	141	234	156
Loans, current	0%	5	5	4	3	3	2
Total current financial assets	17.4%	3,223	2,746	3,270	3,028	2,699	2,781
Inventories	-2.9%	2,467	2,541	2,271	2,279	2,218	2,230
Total current assets	9.7%	6,171	5,623	5,879	5,611	5,272	5,314
Property, plant and equipment	0.1%	3,458	3,455	3,217	3,297	3,192	2,772
Capital work-in-progress	33.1%	488	367	412	281	263	688
Goodwill	0.3%	340	339	339	338	337	338
Non-current investments	0%	44	44	42	32	43	43
Loans, non-current	50%	4	3	3	3	2	2
Total non-current financial assets	-6.3%	75	80	68	72	100	94
Total non-current assets	-0.5%	9,323	9,367	9,209	9,450	9,457	9,683
Total assets	3.5%	15,515	14,990	15,088	15,061	14,744	15,012
Borrowings, non-current	-12.3%	1,045	1,192	1,414	1,604	2,110	2,496
Total non-current financial liabilities	-3.8%	1,300	1,352	1,497	1,677	2,170	2,570
Provisions, non-current	8%	541	501	446	445	408	393
Total non-current liabilities	-1.9%	2,631	2,682	2,737	2,779	3,139	3,367
Borrowings, current	-15.8%	1,545	1,834	1,634	2,334	2,306	2,801
Total current financial liabilities	-8.8%	3,719	4,077	4,144	4,728	4,362	4,919
Provisions, current	12.8%	460	408	435	400	405	394
Current tax liabilities	35.8%	130	96	91	168	8	31
Total current liabilities	-6%	4,435	4,717	4,847	5,426	4,898	5,447
Total liabilities	-4.5%	7,066	7,399	7,584	8,205	8,037	8,814
Equity share capital	0%	169	169	169	169	169	169
Total equity	11.3%	8,449	7,591	7,504	6,856	6,707	6,198
Total equity and liabilities	3.5%	15,515	14,990	15,088	15,061	14,744	15,012

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	-39.4%	64	105	91	105	81	85
Current investments	-20.7%	89	112	85	141	234	156
Loans, current	33.3%	5	4	4	3	3	2
Total current financial assets	21.4%	3,062	2,522	2,280	1,937	2,064	2,095
Inventories	-4.4%	1,493	1,561	1,428	1,566	1,577	1,602
Total current assets	13.8%	4,951	4,349	3,958	3,742	3,919	3,926
Property, plant and equipment	-1%	3,101	3,132	3,132	3,205	3,113	2,688
Capital work-in-progress	33%	485	365	247	204	235	675
Goodwill	0%	324	324	324	324	324	324
Non-current investments	7.3%	441	411	403	322	218	205
Loans, non-current	50%	4	3	3	3	2	3
Total non-current financial assets	6%	457	431	424	342	238	220
Total non-current assets	-1.6%	8,353	8,493	8,450	8,635	8,704	8,946
Total assets	3.8%	13,325	12,842	12,408	12,377	12,623	12,872
Borrowings, non-current	-15.1%	867	1,021	1,414	1,604	1,944	2,332
Total non-current financial liabilities	-7.1%	1,026	1,104	1,442	1,620	1,963	2,360
Provisions, non-current	8.3%	366	338	289	282	260	245
Total non-current liabilities	-4.1%	2,177	2,270	2,525	2,559	2,784	3,007
Borrowings, current	-26.2%	1,127	1,526	1,127	1,729	1,733	2,234
Total current financial liabilities	-13.2%	2,254	2,598	1,978	2,697	2,723	3,183
Provisions, current	14.6%	237	207	210	171	172	151
Current tax liabilities	70.8%	124	73	73	30	0	-
Total current liabilities	-9.6%	2,693	2,980	2,357	2,989	2,974	3,409
Total liabilities	-7.2%	4,870	5,250	4,882	5,548	5,758	6,416
Equity share capital	0%	169	169	169	169	169	169
Total equity	11.4%	8,455	7,592	7,526	6,829	6,865	6,456
Total equity and liabilities	3.8%	13,325	12,842	12,408	12,377	12,623	12,872

Capital Structure & Leverage
Debt Ratio	0.17
Debt/Equity	0.31
Interest Coverage	13.67

Financial Health
Current Ratio	1.39
Debt/Equity	0.31

Category	TORNTPHARM	Pharmaceuticals
PE	65.27	36.29
PS	11.72	5.01
Growth	11.2 %	8.8 %

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-28.7%	252	353	333	255	-	-
Change in inventories	-426%	-262	-49	256	219	-	-
Depreciation	-1.6%	795	808	707	662	-	-
Unrealised forex losses/gains	72.4%	-15	-57	-49	-36	-	-
Adjustments for interest income	90%	20	11	0	0	-	-
Net Cashflows from Operations	-15.3%	3,188	3,764	2,766	2,224	-	-
Income taxes paid (refund)	21.1%	603	498	398	421	-	-
Net Cashflows From Operating Activities	-20.9%	2,585	3,266	2,368	1,803	-	-
Cashflows used in obtaining control of subsidiaries	-	0	0	1,941	0	-	-
Cash payment for investment in partnership firm or association of persons or LLP	-	10	0	0	0	-	-
Proceeds from sales of PPE	-87.2%	18	134	159	6	-	-
Purchase of property, plant and equipment	41.2%	611	433	574	203	-	-
Interest received	58.3%	20	13	13	7	-	-
Other inflows (outflows) of cash	-102.6%	-2	118	-13	-8	-	-
Net Cashflows From Investing Activities	-220.1%	-540	-168	-2,356	-198	-	-
Proceeds from borrowings	-	0	0	2,237	219	-	-
Repayments of borrowings	-32.4%	926	1,369	972	1,033	-	-
Payments of lease liabilities	13%	27	24	22	0	-	-
Dividends paid	6.7%	1,083	1,015	863	677	-	-
Interest paid	-29.5%	262	371	303	258	-	-
Net Cashflows from Financing Activities	17.3%	-2,298	-2,779	77	-1,781	-	-
Effect of exchange rate on cash eq.	-242.9%	-9	8	21	1	-	-
Net change in cash and cash eq.	-180.7%	-262	327	110	-175	-	-

TORNTPHARM - Torrent Pharmaceuticals Ltd. Share Price

TORNTPHARM

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

TORNTPHARM

TORNTPHARM - Torrent Pharmaceuticals Ltd. Share Price

TORNTPHARM

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

TORNTPHARM

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Torrent Pharmaceuticals Ltd. do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Torrent Pharmaceuticals Ltd. do?

Important Disclosure & Data Context